This article summarizes ISMP’s alert about vials of neuromuscular blocking agents lacking a warning label on their caps entering the market and includes ISMP recommendations for pharmacists to prevent errors.
For the full text, visit Pharmacy Practice News online. Please note that access may require free registration.
More News
Since the 2021-2022 influenza (flu) vaccine became available in September, the Institute for Safe Medication Practices (ISMP) has received multiple reports of mix-ups. Some patients have consented to a flu vaccine but received one of the COVID-19 vaccines instead, while others have received the flue
This news brief appeared in the OR Manager newsletter on September 16, 2021.
ECRI and its affiliate, the Institute for Safe Medication Practices (ISMP), advocate for safe maternal and newborn care; launches site with free resources and safety guidance.